Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a...
The DaBlaCa-15 trial paves the way for urinary biomarker integration Reviewed by Joost Boormans Non-muscle-invasive bladder cancer (NMIBC) demands diligent and often lifelong surveillance, primarily through frequent cystoscopies. While crucial for detecting...
